drugset / Trial / NCT05157360
HAT for the Treatment of Sepsis Associated With NASTI
RandomizedParallel-groupTriple-blindTreatment
Summary
Evaluate the impact of HAT therapy versus placebo in the treatment of patients with an acute NSTI and sepsis.
Timeline
- Start
- 2021-09-10
- Primary completion
- 2023-05-16
- Completion
- 2023-05-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrocortisone | Other / unclassified | 50 mg | — |
| Subject | Thiamine | Other / unclassified | 200 mg | — |
| Subject | Vitamin C | Other / unclassified | 1.5 g | — |